Cat urinary health: treatment and prevention research

Research on feline urinary health addresses several different problems. Some experiments measure urine in healthy cats. Others follow cats with bladder inflammation, test stone-dissolving foods or count blockages after hospital treatment. Reading them as one body of “prevention evidence” can make their findings seem more certain or more widely applicable than they are.

This review separates those outcomes and explains the limits of MSRA’s source set. For practical next steps, start with the owner guides.

A cat repeatedly straining with little or no urine needs immediate veterinary assessment. Contact a veterinary clinic now, including if you are unsure whether urine is passing. Research reading must not delay care. PDSA: blocked bladder in cats

What this review covers

The inherited public bibliography contains 40 publications: 34 primary empirical papers and six reviews. The local working bibliography adds the 2025 iCatCare consensus guideline as reference 41. A publication count is not a count of independent trials: reviews include primary papers, and different publications can describe related work. The source index preserves the reference numbers and identifies their broad populations and purposes.

Our focus is the relationship between food/water choices, urinary measurements and clinical outcomes, plus selected interventions studied after obstruction or in FIC. FIC means feline idiopathic cystitis. It should not be used as a catch-all label for every cat with urinary signs.

This is not a complete review of surgery, costs, environmental care, all drugs or all new publications. Supplementary clinical guidance and selected later leads help interpret the inherited set; they have not been silently counted as part of its original review workflows.

How the evidence was assembled—and what cannot yet be verified

The inherited project report describes two PubMed/EuropePMC literature-review workflows, dated 24 June and 20 August 2026. It reports 46 inclusions in the first and 29 in the second, with substantial abstract-only assessment. These are reported review memberships. The underlying complete screening, exclusion and extraction registries are not available in the recovered project files, so their combined deduplicated publication count and per-record reading history cannot be reconstructed.

The October audit matched the 41 numbered references to original records and checked claims using a mixture of relevant original full-text sections, indexed sections and abstracts. Later targeted checks improved access to particular papers, including the published Macleod review and the Hanson prazosin trial. Access varies by source; a link to a free paper does not establish that its full methods were appraised.

No formal independent risk-of-bias assessment has been completed for this MSRA synthesis. We do not reproduce the earlier assertion that every underlying statement was verified from a full original paper. We also cannot establish complete PRISMA reporting from the recovered materials. This revision is a bounded evidence review and correction exercise, rather than a new systematic-review completion claim.

Match the result to the question

Finding type	Example in this source set	What remains a different question
Water balance and urine chemistry	Food-moisture experiments in healthy cats	Fewer painful episodes or blockages in affected pets
Diet-associated stone dissolution	Selected foods in cats with suspected struvite stones	Whether ordinary wet food has the same effect; long-term recurrence
Recurrence of FIC signs	Clinical diet studies in cats with nonobstructive FIC	Confirmed repeat obstruction after catheter treatment
Repeat obstruction	Post-treatment drug trials and observational studies	Pain relief, treatment of proven infection, or benefit in an excluded population
A synthesis or guideline	A review of prior studies; expert clinical recommendations	A further independent group of treated cats

Food moisture: useful urine changes, limited prevention inference

A randomized feeding experiment in 36 healthy cats compared four formulations differing in food moisture and starch/protein balance. Higher moisture increased water intake and urine volume and reduced measured relative supersaturation. That measure estimates the tendency of certain minerals to precipitate under the test conditions. It is not a guarantee about stone formation in an individual cat. The experiment did not measure fewer blockages or FIC episodes. Gonçalves Tozato et al., 2024

An older clinical study followed 46 of 54 enrolled cats with FIC for a year. It reported no recurrence in 16/18 cats fed the canned therapeutic food and 17/28 fed its dry version. Allocation is not established as random in the available abstract, and follow-up was incomplete. This is clinical evidence about particular foods and FIC signs, rather than proof that any ordinary wet food prevents obstruction. Markwell et al., 1999

Drinking systems: average results and individual preferences

In one randomized crossover study, 14 healthy laboratory cats completed comparisons of still, circulating and free-falling water systems. Average intake, urine volume, specific gravity and relative supersaturation did not significantly differ. Circulating water produced higher urine osmolality, another concentration measure, whose clinical relevance was uncertain. It would be inaccurate to say that every urinary measure was unchanged. Robbins et al., 2019

A separate study in healthy pet cats found slightly greater measured intake with a fountain but no significant urine-osmolality difference; 12 cats completed the comparison. Device water loss and a cat’s acceptance of the fountain also matter when interpreting intake. Neither study established fewer clinical blockages. Grant, 2010

Struvite dissolution: keep the denominator and diagnosis

Houston and colleagues used 21 cats: stones dissolved in 17, and the four nonresponders had calcium oxalate or calcium phosphate stones. Wet/dry format was owner-selected. The result is not “17 cats, minus four failures.” Houston et al., 2011

A later randomized study compared two dissolution foods in 37 cats, with complete dissolution in 32. Its comparator was another dissolution food, not ordinary wet food. Lulich et al., 2013

These findings support keeping stone type, formulation and veterinary follow-up attached to a dissolution claim. Dissolution is not emergency relief of a blocked urethra. The food guide explains the decisions without turning study timelines into an at-home treatment schedule.

Repeat obstruction: a percentage needs a population and a clock

In the 2021 Hanson trial, 80 cats with first-time obstruction were enrolled and 65 were analyzed. Repeat obstruction occurred in 11/37 prazosin-treated cats and 5/28 placebo-treated cats; the difference was not statistically significant (P=.27). Ten of the 16 events occurred in hospital. Describing this as a one-in-four risk for cats already discharged home would change the population and timing. The trial did not demonstrate a preventive benefit, equivalence or drug-caused harm. Hanson et al., 2021

The Conway study used observational surveys through veterinarians who always or never prescribed prazosin. It reported more repeat obstructions in the treated group. This is a signal requiring interpretation, rather than a randomized causal estimate. The recovered design description does not substantiate the earlier MSRA explanation that difficult cases were preferentially prescribed the drug; that explanation has been removed. Conway et al., 2022

The recovery guide explains why observed straining is also different from confirmed obstruction. The medicines guide puts these findings beside a prescription’s actual purpose.

FIC diets: episodes and cats are different outcomes

A randomized masked diet trial enrolled 31 cats with nonobstructive FIC and analyzed 25. It reported 4/11 versus 9/14 cats with a multiple-sign episode, a difference that was not statistically significant. Episode rates were 0.7 versus 5.4 per 1,000 cat-days between groups. These are two different endpoints; the latter is not a before-and-after fall in the same cats. Multiple nutrients differed, and six cats were excluded. Full correspondence appraisal remains incomplete. Kruger et al., 2015

A 2025 systematic review identified tailored environmental modification and therapeutic urinary foods, especially with increased dietary moisture, as the approaches with the strongest available support for recurrent FIC. It also emphasized the shortage of high-quality studies. Its last search was 31 May 2023; it assigned Oxford evidence levels but did not conduct a further formal methodological-quality/risk-of-bias appraisal. Its publication year is therefore not its evidence-search cutoff. Macleod et al., 2025, published paper

Other findings that need careful boundaries

• Pain and prevention: failure to demonstrate fewer blockages does not establish no pain-relieving benefit. The corrected meloxicam study reports P=.70, not .07; its recurrence result was underpowered. Nivy et al., 2019, corrected paper
• Pilot counts: a bladder glycosaminoglycan pilot randomized 14 unique cats, seven per group. Two later crossover exposures explain the pooled 0/9 versus 3/7 comparison. Calling it a 16-cat randomized trial double-counts cats. Bradley and Lappin, 2014
• New drug evidence: a 2026 lorazepam trial is a single, selected first-obstruction study with incomplete full-method appraisal in this project and reported adverse effects. It is a research lead, rather than a basis for an owner treatment recommendation. Splittstoesser et al., 2026
• Supplements: a preliminary cranberry-containing formulation study and a healthy-cat herbal-compound experiment do not establish general obstruction prevention or the effect of an isolated ingredient. Colombino et al., 2022, Martin et al., 2026

What these results mean for an owner

Find out the diagnosis or working diagnosis, the intended purpose of each treatment and how the clinic will review it. Tell the team if food refusal, medicines, shared trays, costs or transport make the plan difficult. Use the free record to organize observations and instructions, without delaying care.

This evidence set does not establish a universal prevention plan, an MSRA product’s efficacy, a Maine Coon-specific treatment or a safe period to wait during suspected obstruction. Unknowns should lead to a better question or further research, rather than a stronger headline.

Revision and transparency

This proposed revision corrects stone-dissolution and pilot denominators, recurrence timing, FIC endpoint wording and an unsupported confounding explanation. It makes source access and missing methods explicit, removes owner drug doses and laboratory targets, and distinguishes urine changes from clinical benefit. The original studies retain their own publication dates. MSRA’s interpretation date is 29 October 2026; the actual public revision date should be recorded when this version is released.

Find all numbered records in the source index. The experiments belong to their original researchers. MSRA has not conducted the clinical studies described here.

Prepared by MSRA Research with AI assistance. Interpretation prepared 29 October 2026. Qualified veterinary review has not been completed.